Chronic Cough: Evolution of the Therapeutic Landscape to Reduce the...

Actions Panel

Chronic Cough: Evolution of the Therapeutic Landscape to Reduce the...

CME Lunch Symposium

When and where

Date and time


Omni Nashville 250 Rep. John Lewis Way S Nashville, TN 37203

Map and directions

How to get there

About this event

Activity Chair

Peter Dicpinigaitis, MD, FCCP

Professor of Medicine, Albert Einstein College of Medicine

Division of Critical Care Medicine, Montefiore Medical Center

Director, Montefiore Cough Center

Bronx, NY



Clinical Professor of Medicine and Pediatrics

Morsani School of Medicine

University of South Florida

Tampa, FL

Krishna M. Sundar, MD, FCCP

Clinical Professor, Department of Medicine

Division of Pulmonary and Critical Care Medicine

Medical Director, Sleep-Wake Center

University of Utah

Salt Lake City, UT


Chronic cough—lasting more than 8 weeks—impacts up to 13% of the US population. It may be associated with a wide array of pulmonary or extrapulmonary conditions, and 70% of patients with this condition have at least 3 clinical encounters before an accurate determination of the etiology. More than half of patients who receive conventional treatment report that their symptoms remain uncontrolled, significantly affecting their daily activities and quality of life. With new agents on the horizon for managing unexplained and refractory chronic cough, it is vital that clinicians are poised to identify patients who may benefit from emerging therapies. In this educational symposium, featuring a Rapid-Fire Roundtable discussion, experts will discuss the health and economic burden of chronic cough as well as its significant impact on patient quality of life. Faculty will review strategies for identifying the underlying causes, the recommended approaches for empiric treatment, and the clinical evidence on current and emerging therapies in this therapeutic landscape.


11:30 AM

Registration and Lunch

12:00 PM

Introduction and Pretest

Peter Dicpinigaitis, MD

12:04 PM

Health and Economic Burden of Chronic Cough

Krishna M. Sundar, MD

12:12 PM

Rapid-Fire Roundtable

12:17 PM

Identifying the Patient With Chronic Cough

Mandel Sher, MD

12:25 PM

Rapid-Fire Roundtable

12:30 PM

Chronic Cough Management: The Emerging Therapeutic Landscape

Peter Dicpinigaitis, MD

12:45 PM

Rapid-Fire Roundtable

12:50 PM

Posttest and Question & Answer

1:00 PM


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Evaluate the health and economic burden of chronic cough as well as tools to assess its impact on patient quality of life.

  • Examine patient- identification strategies and underlying causes of chronic cough.

  • Review clinical evidence regarding the safety and efficacy of current and investigational therapies for chronic cough.

Target Audience

The intended audience for this activity is pulmonologists, nurse practitioners, and other health care professionals involved in the management of patients with chronic cough.

This continuing medical education activity is provided by Vindico Medical Education.

This activity is supported by an educational grant from Merck & Co., Inc.

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

Faculty, topics, program schedule, and credit hours are subject to change. Recording of any manner is prohibited without written permission from Vindico Medical Education, Office of Medical Affairs and Compliance.